PHI with Malignant pleural mesothelioma
How does this condition affect your private health insurance?
Rippenfellkarzinom, also known as pleural mesothelioma, is a rare but highly aggressive cancer originating in the pleura, the lining of the lungs. Its primary cause is prolonged exposure to asbestos fibers. Symptoms often develop decades after exposure and typically include shortness of breath, chest pain, and unexplained weight loss. Diagnosis is challenging and usually involves imaging, biopsy, and immunohistochemistry. The disease progresses rapidly, leading to significant respiratory compromise. Treatment options, often palliative, include surgery, chemotherapy, and radiation, but a cure is uncommon due to its late detection and invasive nature.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several months to over one year from symptom onset to diagnosis and initial treatment.
Duration of Illness (Lifetime)
Generally 12-21 months after diagnosis; a terminal illness.
Cost of Treatment (Initial)
Very high (tens of thousands to hundreds of thousands of USD).
Cost of Treatment (Lifetime)
Extremely high (hundreds of thousands of USD).
Mortality Rate
Extremely high (over 90% within 5 years).
Risk of Secondary Damages
High (respiratory failure, severe pain, cachexia, mental health impacts).
Probability of Full Recovery
Very low (less than 5%).
Underlying Disease Risk
Moderate to high, particularly for asbestos-related conditions like asbestosis or pleural plaques.